Hester Biosciences Limited (HESTERBIO.NS)
INR 2459.15
(1.23%)
INR 2459.15
(1.23%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.81 Billion INR | 117.96% |
| 2022 | 833.97 Million INR | -50.89% |
| 2021 | 1.69 Billion INR | 92.91% |
| 2020 | 880.26 Million INR | 7.78% |
| 2019 | 816.69 Million INR | 39.96% |
| 2018 | 583.51 Million INR | 59.69% |
| 2017 | 365.39 Million INR | -18.11% |
| 2016 | 446.21 Million INR | 35.6% |
| 2015 | 329.07 Million INR | 4.42% |
| 2014 | 315.14 Million INR | 103.06% |
| 2013 | 155.19 Million INR | 13.19% |
| 2012 | 137.11 Million INR | 964.02% |
| 2011 | 12.88 Million INR | -93.96% |
| 2010 | 213.24 Million INR | 5.84% |
| 2009 | 201.48 Million INR | 7.37% |
| 2008 | 187.66 Million INR | -6.83% |
| 2007 | 201.42 Million INR | -9.91% |
| 2006 | 223.57 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 1.54 Billion INR | 0.0% |
| 2023 FY | 1.81 Billion INR | 117.96% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.96 Billion INR | 0.0% |
| 2023 Q4 | 1.81 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 833.97 Million INR | 0.0% |
| 2022 Q2 | 1.95 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 833.97 Million INR | -50.89% |
| 2021 Q2 | 878.28 Million INR | 0.0% |
| 2021 Q4 | 1.69 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 1.69 Billion INR | 92.91% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 880.26 Million INR | 7.78% |
| 2020 Q4 | 880.26 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 1.07 Billion INR | 0.0% |
| 2019 Q2 | 562.15 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 816.69 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 816.69 Million INR | 39.96% |
| 2018 FY | 583.51 Million INR | 59.69% |
| 2018 Q4 | 583.51 Million INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 365.39 Million INR | -18.11% |
| 2016 FY | 446.21 Million INR | 35.6% |
| 2015 FY | 329.07 Million INR | 4.42% |
| 2014 FY | 315.14 Million INR | 103.06% |
| 2013 FY | 155.19 Million INR | 13.19% |
| 2012 Q2 | 104.38 Million INR | 0.0% |
| 2012 FY | 137.11 Million INR | 964.02% |
| 2012 Q4 | 137.11 Million INR | 0.0% |
| 2011 FY | 12.88 Million INR | -93.96% |
| 2010 FY | 213.24 Million INR | 5.84% |
| 2009 FY | 201.48 Million INR | 7.37% |
| 2008 FY | 187.66 Million INR | -6.83% |
| 2007 FY | 201.42 Million INR | -9.91% |
| 2006 FY | 223.57 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 265.79 Million INR | -583.876% |
| Ind-Swift Limited | 10.09 Billion INR | 81.994% |
| Bajaj HealthCare Limited | 650.34 Million INR | -179.502% |
| Sakar Healthcare Limited | 549.55 Million INR | -230.767% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 91.486% |
| Innova Captab Limited | 2.1 Billion INR | 13.655% |
| Divi's Laboratories Limited | 20 Million INR | -8988.65% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -6430.141% |
| Morepen Laboratories Limited | 33.64 Million INR | -5303.478% |
| Mankind Pharma Limited | 325.81 Million INR | -457.902% |
| Sequent Scientific Limited | 1.42 Billion INR | -27.364% |
| Wanbury Limited | 820 Million INR | -121.674% |
| Laurus Labs Limited | 7.98 Billion INR | 77.228% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -29.552% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -1131.441% |
| Alembic Limited | 73.9 Million INR | -2359.716% |
| Hikal Limited | 4.22 Billion INR | 57.012% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -189.079% |
| Neuland Laboratories Limited | 449.2 Million INR | -304.654% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -668.921% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -19.831% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Themis Medicare Limited | 267.74 Million INR | -578.916% |
| RPG Life Sciences Limited | -30.3 Million INR | 6099.109% |
| Zydus Lifesciences Limited | 251 Million INR | -624.195% |
| Lupin Limited | 1.55 Billion INR | -17.061% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -12913.531% |
| Wockhardt Limited | 8.91 Billion INR | 79.599% |
| Vaishali Pharma Limited | 35.98 Million INR | -4951.635% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -454332.5% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -2305.359% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 94.261% |
| FDC Limited | 2.46 Million INR | -73611.679% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 69.654% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Eris Lifesciences Limited | 6.54 Billion INR | 72.227% |
| Venus Remedies Limited | 386.8 Million INR | -369.941% |
| ZIM Laboratories Limited | 356 Million INR | -410.59% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -410.71% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -19657.935% |
| Shilpa Medicare Limited | 5.6 Billion INR | 67.55% |
| Albert David Limited | 6.01 Million INR | -30114.927% |
| Ajanta Pharma Limited | 235.2 Million INR | -672.844% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -755.982% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | -54.779% |
| Gufic Biosciences Limited | 1.53 Billion INR | -18.063% |
| Windlas Biotech Limited | 20.18 Million INR | -8907.582% |
| Procter & Gamble Health Limited | 68.8 Million INR | -2542.049% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -5537.462% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -1261.177% |
| Granules India Limited | 689.71 Million INR | -163.55% |
| Aarti Drugs Limited | 2.75 Billion INR | 33.98% |
| Bal Pharma Limited | 363.82 Million INR | -399.618% |
| Alkem Laboratories Limited | 400 Million INR | -354.433% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -13567.143% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Medicamen Biotech Limited | 12.55 Million INR | -14378.136% |
| Unichem Laboratories Limited | 382.22 Million INR | -375.57% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -1590.408% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Valiant Laboratories Limited | 750.89 Million INR | -142.074% |
| Orchid Pharma Limited | 1.2 Billion INR | -50.937% |
| Medico Remedies Limited | 8.67 Million INR | -20860.909% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -1528.411% |
| Ipca Laboratories Limited | 5.8 Billion INR | 68.682% |
| Brooks Laboratories Limited | 3.56 Million INR | -50888.219% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 149216.489% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.661% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 88.668% |
| NATCO Pharma Limited | 53 Million INR | -3329.679% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 0.941% |
| Strides Pharma Science Limited | 6.71 Billion INR | 72.93% |
| Indoco Remedies Limited | 3.51 Billion INR | 48.32% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -1605.188% |